GRINT PAUL C 4
4 · Inhibikase Therapeutics, Inc. · Filed Jun 29, 2021
Insider Transaction Report
Form 4
GRINT PAUL C
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-25+22,677→ 22,677 totalExercise: $2.92From: 2022-06-25Exp: 2028-06-25→ Common Stock (22,677 underlying)